Mercado mundial de albúmina de suero bovino: tendencias de la industria y pronóstico hasta 2029

Análisis y tamaño del mercado de albúmina de suero bovino

Se espera que el mercado de albúmina sérica bovina experimente importantes oportunidades de crecimiento en los próximos años. Este creciente crecimiento del mercado se debe a la introducción de un producto novedoso en el campo de la albúmina sérica bovina. Además, el aumento de este suero como proteína de suero dietético está impulsando las oportunidades de crecimiento del mercado.

Data Bridge Market Research analiza que se espera que el mercado de albúmina de suero bovino, que se valoró en USD 5.58 mil millones en 2021, alcance el valor de USD 18.42 mil millones para 2029, con una CAGR del 16,1% durante el período de pronóstico de 2022-2029. Además de los conocimientos del mercado, como el valor de mercado, la tasa de crecimiento, los segmentos del mercado, la cobertura geográfica, los actores del mercado y el escenario del mercado, el informe de mercado curado por el equipo de Data Bridge Market Research incluye un análisis experto en profundidad, análisis de importación/exportación, análisis de precios, análisis de consumo de producción, análisis de patentes y comportamiento del consumidor.

Alcance y segmentación del mercado de albúmina de suero bovino

Definición de mercado

Albumin is a globular protein that is water soluble and found in blood plasma. It is produced in the liver and is required for blood volume maintenance as well as the transport of enzyme, hormone, and bile salt molecules. It is frequently available in human, bovine, and recombinant forms. They are critical for maintaining intravascular colloid osmotic pressure (COP) and preventing fluid leakage into the tissue.

Bovine Serum Albumin Market Dynamics

Drivers

• Prevalence of chronic diseases around the world

The increasing prevalence of chronic medical ailments around the world is one of the key factors driving market growth. Albumin is commonly used to treat hypovolemia, acute respiratory distress syndrome (ARDS), nephrosis, renal dialysis, liver failure, cardiopulmonary disorders, and hypoalbuminemia. Furthermore, the growing geriatric population, which is more vulnerable to such illnesses, is driving market growth.

• High preference from industry scientist due to its various beneficial characteristics

As a protein standard, various research organisations use bovine serum albumin. It has been used to determine unknown quantities of other proteins while keeping the quantities of bovine serum albumin in mind. Furthermore, bovine serum albumin has no discernible effect on various biochemical reactions. This factor encourages many industry scientists to choose this serum. Other notable characteristics that are expected to boost opportunities in the bovine serum albumin market include high water solubility and high purity.

Opportunity

In contrast, the market is expected to benefit from the development of cost-effective therapeutics through large-scale production and high market potential in untapped emerging economies. People are more aware of their health nowadays, which compels them to maintain their health and increases demand for albumin for drug development. This has prompted many key players to expand into emerging markets, creating a lucrative growth opportunity in the albumin market.

Restraints

However, adverse reactions and a growing shift toward serum-free solutions may impede albumin market growth. The use of albumin substitutes in replacement therapies and other applications may limit the albumin market's growth.

This bovine serum albumin market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the bovine serum albumin market contact Data Bridge Market Research for an Analyst Brief, our saffron will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Bovine Serum Albumin Market

The sudden outbreak of COVID-19 cases has had a negative impact on the development, production, and supply of reagents and consumables. Furthermore, various companies in the bovine serum albumin market have suffered negative effects from the pandemic in the last year. The coronavirus has caused the closure of industrial establishments due to the imposition of lockdown to maintain social distance. Other than essential commodities, the pandemic disrupted other industrial establishments.

Recent Development

• Paclitaxel protein-bound particles for injection (albumin-bound), a generic version of Abraxane, was launched in the United States by Apotex Corp. in April 2022.
• Bio Products Laboratory (BPL) announced in January 2022 that the National Medical Products Administration (NMPA) of China had granted a licence to market ALBUMINEX 25% product in China.

Global Bovine Serum Albumin Market Scope

The bovine serum albumin market is segmented on the basis of product and application. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Human Serum Albumin
• Bovine Albumin
• Recombinant Serum Albumin

Application

• Therapeutic
• Drug Delivery
• Culture Media
• Vaccine Ingredient
• Others

Bovine Serum Albumin Market Regional Analysis/Insights

The bovine serum albumin market is analysed and market size insights and trends are provided by country, product and application as referenced above.

The countries covered in the bovine serum albumin market report are U.S., Canada and Mexico in North America, Germany, Sweden, Poland, Denmark, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Se espera que Asia-Pacífico tenga la mayor participación porcentual del mercado mundial de albúmina sérica bovina durante el período de pronóstico. Los principales factores que impulsan el crecimiento del mercado de albúmina en Asia-Pacífico son un aumento en el uso de albúmina para el tratamiento de enfermedades, la presencia de un gran grupo de pacientes y un mayor enfoque en la mejora del diagnóstico.

Regulación del mercado que impacta las tendencias actuales y futuras del mercado. Puntos de datos como análisis de la cadena de valor ascendente y descendente, tendencias técnicas y análisis de las cinco fuerzas de Porter, estudios de casos son algunos de los indicadores utilizados para pronosticar el escenario del mercado para países individuales. Además, la presencia y disponibilidad de marcas globales y sus desafíos enfrentados debido a la competencia grande o escasa de las marcas locales y nacionales, el impacto de los aranceles nacionales y las rutas comerciales se consideran al proporcionar un análisis de pronóstico de los datos del país.   

Análisis del panorama competitivo y de la cuota de mercado de la albúmina de suero bovino

El panorama competitivo del mercado de albúmina sérica bovina proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento del producto, la amplitud y la variedad del producto, el dominio de la aplicación. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado de albúmina sérica bovina.

Algunos de los principales actores que operan en el mercado de albúmina sérica bovina son:

• Thermo Fisher Scientific (Estados Unidos)
• Laboratorios Bio-Rad, Inc. (Estados Unidos)
• Merck KGAA (Alemania)
• Itoham Yonekyu Holdings Inc (Japón)
• Proliant Biologicals (Estados Unidos)
• Kraeber & Co. Gmbh (Alemania)
• Rockland Immunochemicals Inc (Estados Unidos)
• Productos biológicos de las Montañas Rocosas (EE. UU.)
• Socios de inversión de BelHealth, LLC (EE. UU.)
• Corporación Bio-Techne (Estados Unidos)
• Prospec-Tany Technogene Ltd (Israel)
• Grupo LGC (Reino Unido)
• Corporación Promega (Estados Unidos)
• Industrias Biológicas (Israel)
• Serion GmbH (Alemania)

SKU-54665